Clinical and Translational Science Award

临床和转化科学奖

• 批准号: 8743331
• 负责人: HARRY SHAMOON
• 金额: $ 463.68万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-26 至 2018-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8743331
• 关键词: Abbreviations; Acceleration; Advocacy; Appointment; Area; Award; Big Data; Biological Markers; Biology; Breeding; Caring; Chemicals; Child health care; Clinical; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Commit; Communities; Data; Development; Discipline; Disease; Doctor of Philosophy; Drug Design; Education; Engineering; Ensure; Environment; Epidemiologic Studies; Evolution; Faculty; Fostering; Funding; Generations; Genomics; Goals; Health; Home environment; Institutes; Instruction; Investments; Leadership; Learning; Left; Malignant Neoplasms; Measures; Medical center; Medicine; Mentors; Mission; Modeling; N.I.H. Research Support; National Center for Research Resources; Outcome; Outcomes Research; Paper; Pathway interactions; Principal Investigator; Process; Research; Research Design; Research Infrastructure; Research Personnel; Research Project Grants; Research Training; Resources; Role; Safety; Science; Security; Services; Shapes; Staging; Strategic Planning; Structure; Therapeutic; Time; Training; Training and Education; Translational Research; United States National Institutes of Health; Vision; Work; authority; base; biomedical informatics; career development; catalyst; clinical practice; college; experience; improved; innovation; member; nanoparticle; new technology; novel; patient population; practice-based research network; programs; repository; research clinical testing; working group

This is an applicafion for a Clinical and Translafional Science Award (CTSA) at the Albert Einstein College of Medicine partnered with Montefiore Medical Center. The Einstein-Montefiore Institute for Clinical and Trans- lational Research (ICTR) serves as the home of our CTSA program created in 2007 as the formal research partnership between the two institufions. The ICTR has status as an academic entity with committed space and resources, to advance clinical and translafional research (CTR), with authority to sponsor a PhD in clinical invesfigation and other training and career development programs. The ICTR has transformed CTR within our institufions, and contributed to significant changes beyond our walls. The goals for the new CTSA are; 1) To provide integrated resources and services to support and expedite planning, implementafion, and completion of CTR across the entire range of research; 2) To enhance quality, safety, and efficiency of CTR for all diseases and condifions in our environment; 3) To develop new innovafions that advance clinical and translational sciences; 4) To facilitate the training and career development of a robust translafional research workforce. To accomplish these goals, we propose an integrafive approach with cross-cutting support for T1-T4 translafional sciences, interoperable biomedical informafics, therapeufics development, child health research, and patient- and population-centered outcomes research. We also propose to build on research core services that have evolved and expanded including: 1) Clinical Trials and Regulatory Support Office (CTRSO); 2) Clinical Invesfigafion Services Cores (CISC); 3) Biostafisfics, Epidemiology & Research Design (BERD); 4) Biomarker and Analyfic Research Core (BARC); 5) Biospecimen Repository (BioR); 6) Community Engagement Consultafion Core (CECC); 7) Research Informafics Core (RIC); and 8) Project Accelerafion Resource (PAR). Our Research Training, Education and Career Development program will create an educational environment with a learner-centered approach; focus on the core competencies developed by the CTSA; provide a menu of options to serve learners at various stages of development across the spectrum of clinical and translafional research; and to implement novel mentoring approaches. RELEVANCE (See instructions): This CTSA applicafion proposes an Institufional Clinical and Translafional Science Award (U54) program that conforms to the mission of the Nafional Center for Advancing Translafional Sciences, as expressed in RFA- TR-12-006.

这是阿尔伯特·爱因斯坦学院临床和转化科学奖 (CTSA) 的申请 医学与蒙蒂菲奥里医疗中心合作。爱因斯坦-蒙蒂菲奥里临床与转化研究所 关系研究 (ICTR) 是我们 2007 年创建的 CTSA 项目的所在地，作为正式研究 两个机构之间的伙伴关系。卢旺达问题国际法庭具有学术实体的地位，并拥有承诺的空间 和资源，以推进临床和转化研究（CTR），并有权赞助以下领域的博士学位： 临床调查和其他培训和职业发展计划。卢旺达问题国际法庭改变了 CTR 在我们的机构内部，并为我们之外的重大变化做出了贡献。新 CTSA 的目标 是; 1) 提供综合资源和服务，支持和加快规划、实施和实施 完成整个研究范围的 CTR； 2) 提高CTR的质量、安全性和效率 针对我们环境中的所有疾病和状况； 3）开发新的创新，推进临床和 转化科学； 4) 促进强有力的转化研究的培训和职业发展 劳动力。为了实现这些目标，我们提出了一种具有跨领域支持的综合方法 T1-T4 转化科学、可互操作的生物医学信息学、治疗开发、儿童健康 研究以及以患者和人群为中心的结果研究。我们还建议以研究为基础 已发展和扩展的核心服务包括： 1) 临床试验和监管支持办公室 （CTRSO）； 2) 临床研究服务核心（CISC）； 3) 生物统计学、流行病学和研究设计 （伯德）； 4) 生物标志物和分析研究核心（BARC）； 5) 生物样本库（BioR）； 6）社区参与咨询核心（CECC）； 7) 研究信息学核心（RIC）； 8) 项目 加速资源 (PAR)。我们的研究培训、教育和职业发展计划将 创建以学习者为中心的教育环境；专注于核心能力 由 CTSA 开发；提供一系列选项，为处于不同发展阶段的学习者提供服务 跨越临床和转化研究的各个领域；并实施新颖的指导方法。 相关性（参见说明）： 该 CTSA 申请提出了一项机构临床和转化科学奖 (U54) 计划，该计划 符合国家促进转化科学中心的使命，如 RFA- 中所述 TR-12-006。